Digital technologies are playing a critical role in transforming both how and what is measured in Alzheimer’s disease. Digital cognitive assessments (DCAs) are reshaping early detection and endpoint sensitivity, while electronic Clinical Outcome Assessment (eCOA) solutions are enabling patient, caregiver, and rater-friendly data capture solutions that deliver higher quality data across all stages of the disease.
In this fireside-chat-style webinar, the expert speakers will explore how DCAs and eCOA each contribute to improving Alzheimer’s trials and how, together, they offer a powerful, complementary approach. From early-stage identification and intervention to studies involving patients with symptomatic disease, the webinar will examine how thoughtful digitization can enhance endpoint data quality, reduce participant, and site burden and provide deeper insight into patient experience.
Access this webinar to learn scientific perspective, clinical insights, and real-world examples to uncover what is possible when thoughtful technology development meets the needs of both the data and people behind it.
Speakers
Kaycee Sink, MD, MAS
Chief Medical Officer, Cogstate
Paul O’Donohoe,
Senior Director, eCOA Product & Science, Medidata
